Clinical Trials · NCT02423824
Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University Health Network, Toronto
- Enrollment
- 21
- Start date
- May 2015
- Locations
- 1 site, Canada
- Primary endpoint
- Executive function